As a part of CECP’s mission to create a better world through business, we’ve developed a variety of opportunities to share company stories and case studies that demonstrate excellence in applying the skills and resources of the business to solve societal challenges. 

CECP, in partnership with the Biopharma Sustainability Roundtable, hosted its first-ever virtual, sector specific Biopharma CEO Investor Forum. The 2021 Biopharma CEO Investor Forum featured nine CEO presentations representing $850 billion in aggregate market capitalization to a virtual audience of over 1,000 institutional investors, analysts, company executives, and others. 

This paper analyzes the accessibility, quantity, and time frame of forward-looking information disclosed by the 25 constituents in the S&P 500 Pharmaceuticals, Biotechnology & Life Sciences GICS industry classifications.

Former Chairman and CEO of Best Buy Hubert Joly provided his perspective on leadership and success(ion) planning. Ahead of his new book, The Heart of Business: Leadership Principles for the Next Era of Capitalism, Joly discussed what he calls “human magic” and how to mobilize people to give their best as business, with people at the … Continue reading

This event builds upon collaborative work that started when the Covid-19 pandemic hit in the spring of 2020. During that time, ACCP, CECP, Council on Foundations, and Points of Light came together to support leaders of corporate purpose in acting with courage and determination to respond to the compounding health and economic crises. The executive … Continue reading

Carmine Di Sibio, CEO, EY led a discussion on CEO priorities as we emerge from the Covid-19 pandemic, bringing in recent EY research from the CEO Imperative Series.  This session focused on what “building back better” looks like, the difficulties and opportunities of a stakeholder-focused strategy, and efforts to shift ESG reporting from chasing compliance to projecting long-term … Continue reading

Co-authored by CECP’s CEO Investor Forum and the Biopharma Sustainability Roundtable, the Integrating Sustainability Report provides sector-specific tools for biopharma CEOs and their teams as they prepare their sustainable Long-Term Plans for investors.

Vanguard Chair Bill McNabb and NRG President & CEO Mauricio Gutierrez shared their insights on the power of sharing Long Term Plans, from the corporate issuer and investor perspectives. The conversation focused on how investor expectations are changing as demand for longer-term, forward-looking disclosures continue to grow, including integrating material ESG issues and metrics.

​​​​​​​CECP’s Value Volunteering report brings together focus groups of corporate practitioners, interviews with and a survey of nonprofits, a public opinion survey, and a synthesis of research on volunteering.

Richard Edelman, CEO, Edelman sets the stage with his insights on trust in business in the context of the Covid-19 response and recovery and US presidential election. Featuring the latest findings of the Edelman 2021 Trust Barometer. More information to come.